Aldeyra Therapeutics Inc (NAS:ALDX)
$ 3.79 -0.08 (-2.07%) Market Cap: 225.18 Mil Enterprise Value: 112.55 Mil PE Ratio: 0 PB Ratio: 1.98 GF Score: 41/100

Aldeyra Therapeutics, Inc. - Special Call Transcript

Dec 03, 2019 / 01:00PM GMT
Release Date Price: $5.06 (-32.44%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to this morning's Aldeyra Therapeutics Conference Call. (Operator Instructions) I would now like to hand the conference over the company's Chief Financial Officer, Joshua Reed. Thank you. Please go ahead, sir.

Joshua Reed
Aldeyra Therapeutics, Inc. - CFO

Good morning, everyone. With me today are Dr. Todd Brady, President and Chief Executive Officer of Aldeyra; Dr. David Clark, Chief Medical Officer; and Mr. David McMullin, Chief Commercial Officer.

As is summarized on Slide 2, please note that this morning's conference call and the accompanying presentation contain forward-looking statements regarding future events and the future performance of Aldeyra. Forward-looking statements include statements regarding Aldeyra's possible or assumed future results of operations, expenses and financial position; business strategies and plans; research, development and commercial plans or expectations; trends; market sizing; competitive position; industry environment; and potential growth opportunities,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot